Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Sales (2016 - 2026)

Ironwood Pharmaceuticals' Return on Sales history spans 16 years, with the latest figure at 0.03% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 5.0% to 0.03% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.01%, up 1.0% from a year prior.
  • Return on Sales hit 0.03% in Q4 2025 for Ironwood Pharmaceuticals, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for IRWD hit a ceiling of 0.04% in Q2 2021 and a floor of 0.1% in Q2 2023.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
  • Biggest five-year swings in Return on Sales: decreased -11bps in 2023 and later increased 10bps in 2024.
  • Tracing IRWD's Return on Sales over 5 years: stood at 0.0% in 2021, then surged by 203bps to 0.01% in 2022, then tumbled by -224bps to 0.01% in 2023, then tumbled by -37bps to 0.02% in 2024, then surged by 249bps to 0.03% in 2025.
  • Business Quant data shows Return on Sales for IRWD at 0.03% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.